|

About Us

Home - - About Us


  •     Mab-Venture was established in early 2014 in Shanghai’s Zhangjiang Hi-Tech Park. It is an integrated biotechnology company dedicated to the whole industry chain from research to final product. Mab-Venture is also committed to developing a biopharmaceutical research and development platform, while, carrying out innovative biologics development.     In May 2015, Mab-Venture built a new 1700 sq.m. R&D and pilot production base in Shanghai’s Zhangjiang International Medical Park. In March 2017, Mab-Venture built an additional 3350 sq.m. pilot production base. The two facilities provide an end-to-end solution from research to four pilot production lines to support biologics development and manufacture in the pre-clinical and early clinical stages. R & D equipment investment thus far has been >$20 million dollars. The Mab-Venture team is just over 100 people and is expanding rapidly, with headcount expected to be over 150 by the end of 2017.

        In April 2017, Mab-Venture and Thermo Fisher Scientific signed a strategic cooperation and will jointly establish Asia-Pacific’s first antibody drug "SmartFactory", to accelerate the development of biopharmaceuticals. The center will provide a variety of antibody contract development (CRO) and contract manufacturing (CMO) services.

        The company's Sr. Management team has over 20 years of biologics R&D experience in various areas including; analytical and bioanalytical R&D, process development, cGMP manufacturing, pre-clinical in vivo studies, antibody discovery, and target validation. Mab-Venture’s Senior Management gained its experience working in academia and multinational biopharma such as Amgen, Novartis, J&J, GSK, LifeTech and other leading global biopharmaceutical companies. We have more than 10 years CRO and customer management experience, and have led 17 integrated research and development projects on behalf of domestic and foreign biopharmaceutical companies.


        We provide standalone technical services for various stages of development and also end to end support for biologics R&D from discovery to clinical studies. We are focused on the establishment of a high quality integrated services platform to support global development.

    Our capabilities include but are not limited to:

     ● Technology development and quality method development, validation, and lot release of antibody therapeutics

     ● Cell line development, process development (upstream/downstream), pilot scale production for IND filings / early clinical manufacture

     ● Development and validation of bioanalytical methods

     ● Immunogenicity study and program design

     ● Pharmacodynamic and pharmacokinetic study design and execution

     ● IND filing support and consultation services

        As of August 2016, Mab-Venture had partnerships with SL PHARM,SALUBRIS, Yaobao, Yangtze River, Harbin Pharmaceutical Group, Shanghai Pharma, as well as Tsinghua University, Chinese Academy of Sciences Pasteur, Medical institutions, military academy and other research institutions/organizations.


    Follow us
      WeChat
      
    Contact Us
       info@mab-venture.com
       +86 21 5018 6802
        Ste.2-301,1199 Landian Road,Pudong District,Shanghai 201318,China

             Copyright © 2014 - 2017 上海博威生物医药有限公司 版权所有